摘要
肺动脉高压是以肺动脉压和肺血管阻力升高为特征的进行性疾病,最终导致右心功能衰竭,是慢性肾脏病患者的常见并发症。合并肺动脉高压的慢性肾脏病患者住院和死亡风险增加,是长期生存的重要预测指标。肺动脉高压在慢性肾脏病中的发病机制复杂,目前仍不十分清楚。临床上应早期识别并给予积极治疗。本文就慢性肾脏病患者肺动脉高压的研究进展作一综述。
Pulmonary hypertension is a progressive disease characterized by elevated blood pressure and vascular resistance in pulmonary arteries finally leading to right heart failure.It is a common complication in chronic kidney disease(CKD)patients.CKD patients with pulmonary hypertension have higher risk of hospitalization and death.Therefore,pulmonary hypertension is a unfavorable predictor for survival in CKD patients.The pathogenesis of pulmonary hypertension in CKD patients is complicated and remains elusive.Early identification and active treatment are clinically essential.This article reviews the research progresses in pulmonary hypertension in CKD patients.
作者
蔡蕊莲
席春生
CAI Rui-lian;XI Chun-sheng(Department of Nephrology,The 940th Hospital of Joint Logistics Support Forceof Chinese People's Liberation Army,Lanzhou 730050,China)
出处
《中国血液净化》
CSCD
2019年第5期328-331,共4页
Chinese Journal of Blood Purification
关键词
肺动脉高压
慢性肾脏病
危险因素
治疗
Pulmonary hypertension
Chronic kidney disease
Risk factor
Treatment
